COVID-19 updates, including vaccine information, for our patients and visitors Learn More
View All Releases >
Researchers discover that brain cancer tumors reprogram immune cells to help them grow, rather than suppress them.
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale ...
The UC San Diego Autism Center for Excellence has received a $1.5 million gift from Kristin Farmer, founder and chief executive officer of ACES, a company that provides services to children with autis ...
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
UC San Diego students will participate in nationwide clinical trial to assess if COVID-19 vaccination prevents infection and reduces risk of transmission.
View All Features >
The team at UC San Diego Health takes a family centered approach to treating children for burns that ensures the social, emotional and psychological needs are met for pediatric patients and their fami ...
María Madrigal, receptora de riñón donante, estaba plagada de bacterias multirresistentes; un tratamiento emergente llamado terapia con bacteriófagos resultó ser el remedio.
Donor kidney recipient Maria Madrigal was plagued by multidrug-resistant bacteria; an emerging treatment called phage therapy proved to be the remedy.
Convalescent therapy is a century-old approach adapted to potentially treating and preventing COVID-19 by boosting patients’ neutralizing antibodies. Edward Cachay, MD, leads a clinical trial at UC Sa ...
In the News
View More >
Features UC San Diego Health
Features Judy Davidson, DNP, RN
Features Christopher Longhurst, MD, CIO, ACMO
Features Susan Little, MD
Features Francesca Torriani, MD